PetVivo Is Building the Future of Regenerative Medicine and Biomaterials

PetVivo Holdings (NASDAQ: PETV) is evolving into a next-generation functional biomaterials and medical device company through the strategic acquisition of Piezo Biomembrane. The transaction significantly expands the company's intellectual property portfolio while complementing the commercial success of its Spryng™ with OsteoCushion™ Technology platform. Focused on advancing regenerative medicine and innovative biomaterials, PetVivo is developing technologies designed to improve joint health, tissue repair, and future medical applications. Learn more about the company's vision and growth strategy through New to the Street and discover why investors are taking a closer look at PetVivo. #PetVivo #PETV #RegenerativeMedicine #Biomaterials #MedicalDevices #HealthcareInnovation #Biotechnology #JointHealth #AnimalHealth #BiomedicalEngineering #LifeSciences #NASDAQ #NewToTheStreet #NewsOut #Innovation